AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Metviron GZ Tablet

Prescription Icon
Prescription Required

Marketer

Nvron Life Science Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Metviron GZ Tablet

Glucozym Duo tablets are classified as antidiabetic medications, combining two agents to manage type 2 diabetes in adults. This dual-action formula helps regulate blood glucose. Glucozym Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Carrying a fast-acting glucose source (e.g., sugary snacks, juice) is vital to counteract hypoglycemia. Alcohol consumption elevates hypoglycemia risk and should be limited. Less frequent side effects can include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is a possible consequence. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Metviron GZ Tablet

Non-insulin-dependent diabetes

Major Benefits of Metviron GZ Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metviron GZ Tablet should be administered with food.

Common Side effects of Metviron GZ Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Metviron GZ Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metviron GZ Tablet should be administered with food.

How Metviron GZ Tablet works:

Gliclazide and metformin are combined in Metviron GZ Tablet to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Metviron GZ Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Metviron GZ Tablet during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Metviron GZ Tablet while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Metviron GZ Tablets, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Metviron GZ Tablets. Consult a physician for guidance. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metviron GZ tablets cautiously, potentially requiring dosage modification. Consult your physician. A low initial dose of Metviron GZ tablets is typically recommended for individuals with mild to moderate hepatic dysfunction; however, it's contraindicated in those with severe liver disease.

What if you forget to take Metviron GZ Tablet :

Should you forget a Metviron GZ Tablet dose, administer it promptly. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metviron GZ Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Metviron GZ Tablet

Metviron GZ Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It helps control blood sugar when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Metviron GZ Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Metviron GZ Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Metviron GZ Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). While rare, this side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metviron GZ Tablet and seek immediate medical attention.
Prolonged Metviron GZ Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Metviron GZ Tablets are contraindicated in patients with hypersensitivity to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Metviron GZ Tablet and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Metviron GZ Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. It improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 DM.
Metviron GZ Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Metviron GZ Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This is more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Metviron GZ Tablet use can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect is best avoided in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Metviron GZ Tablet and seek immediate medical attention.
Prolonged Metviron GZ Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Metviron GZ Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Metviron GZ Tablet is unsafe. This combination may cause dangerously low blood sugar and raise the risk of lactic acidosis.
Metviron GZ Tablet
65
MRP 75
13% off